Affiliation: Mayo Clinic
- Current status of antiretroviral therapiesZ Temesgen
Mayo Clinic and Foundation, Division of Infectious Diseases, Rochester, Minnesota 55905, USA
Expert Opin Pharmacother 2:1239-46. 2001..Currently, there are 15 FDA-approved antiretrovirals categorised into three classes of drugs. Several others are in various stages of basic and clinical development...
- [Bone and joint involvement in human immunodeficiency virus infection]Z Temesgen
Division of Infectious Diseases, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
Acta Chir Orthop Traumatol Cech 72:177-82. 2005..This article attempts to provide a broad overview of the complications of HIV and its treatment involving the bone and joints...
- Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART studySean Emery
Therapeutic and Vaccine Research Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria St, Sydney, NSW 2010, Australia
J Infect Dis 197:1133-44. 2008..In the DC group, participants started ART when the CD4+ cell count was <250 cells/microL. Clinical outcomes in participants not receiving ART at entry inform the early use of ART...
- Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-upJens D Lundgren
Copenhagen HIV Programme CHIP, Faculty of Health Sciences, University of Copenhagen, Panum Institute, 2200 Copenhagen N, Denmark
J Infect Dis 197:1145-55. 2008..Rates and predictors of opportunistic disease or death (OD/death) and the relative risk (RR) in DC versus VS groups according to the latest CD4+ cell count and HIV RNA level are reported...
- Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trialW M El-Sadr
Ann Intern Med 149:289-99. 2008..Episodic use of antiretroviral therapy guided by CD4+ cell counts is inferior to continuous antiretroviral therapy...